Good move and hopefully the first of many steps.
Archer has signed an agreement with Hylid Diagnostics to develop an at-home testing device for chronic kidney disease as part of the Biochip project. • Archer and Hylid will combine their respective specialist blood sensing technologies to accelerate development and create a prototype system. • Hylid specialise in medical devices for the at-home testing of blood samples as well as having a team of advisors to aid in the entry of regulatory processes and the setup of clinical trials. • Archer and Hylid are now creating a detailed work plan for the next few months, including the first stage of the project which is to produce stand-alone hemolysis sensors that when used with Archer’s Biochip will meet potassium measurement accuracy requirements.
- Forums
- ASX - By Stock
- AXE
- Ann: AXE partners with Hylid Diagnostics for Biochip development
AXE
archer materials limited
Add to My Watchlist
1.79%
!
27.5¢

Ann: AXE partners with Hylid Diagnostics for Biochip development, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
27.5¢ |
Change
-0.005(1.79%) |
Mkt cap ! $68.80M |
Open | High | Low | Value | Volume |
28.0¢ | 28.0¢ | 27.0¢ | $5.027K | 18.54K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 110675 | 26.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.5¢ | 9717 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 110675 | 0.265 |
6 | 99972 | 0.260 |
9 | 125515 | 0.255 |
19 | 285652 | 0.250 |
4 | 42865 | 0.245 |
Price($) | Vol. | No. |
---|---|---|
0.275 | 9717 | 1 |
0.280 | 14672 | 4 |
0.285 | 36128 | 2 |
0.290 | 62614 | 3 |
0.295 | 5000 | 1 |
Last trade - 13.08pm 16/06/2025 (20 minute delay) ? |
Featured News
AXE (ASX) Chart |